Floatz logo

Tadalafil

Obesity and Erectile Dysfuntion

Centro Universitario de Ciencias de la Salud, MexicoSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Obesity and Erectile Dysfuntion cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Tadalafil is also rated in:

sexual disorderDormant
BBB
Indicative ·
72 / 100
View asset →
erectile dysfunctionDormant
BB
Indicative ·
69 / 100
View asset →
Duchenne muscular dystrophyDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →